CN107259283A - 一种降血压的固体饮料 - Google Patents
一种降血压的固体饮料 Download PDFInfo
- Publication number
- CN107259283A CN107259283A CN201710494683.4A CN201710494683A CN107259283A CN 107259283 A CN107259283 A CN 107259283A CN 201710494683 A CN201710494683 A CN 201710494683A CN 107259283 A CN107259283 A CN 107259283A
- Authority
- CN
- China
- Prior art keywords
- parts
- hypotensive
- chrysanthemum
- solid beverage
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000001953 Hypotension Diseases 0.000 title claims abstract description 40
- 208000021822 hypotensive Diseases 0.000 title claims abstract description 40
- 230000001077 hypotensive effect Effects 0.000 title claims abstract description 40
- 235000013361 beverage Nutrition 0.000 title claims abstract description 38
- 239000007787 solid Substances 0.000 title claims abstract description 38
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 29
- 241000241413 Propolis Species 0.000 claims abstract description 27
- 229940069949 propolis Drugs 0.000 claims abstract description 27
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 26
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 26
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 26
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 26
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 26
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 26
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 26
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 26
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 26
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 26
- 244000000626 Daucus carota Species 0.000 claims abstract description 24
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 24
- 235000003283 Pachira macrocarpa Nutrition 0.000 claims abstract description 23
- 235000014364 Trapa natans Nutrition 0.000 claims abstract description 23
- 235000009165 saligot Nutrition 0.000 claims abstract description 23
- 235000012907 honey Nutrition 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 229940109850 royal jelly Drugs 0.000 claims abstract description 17
- 241000723353 Chrysanthemum Species 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 28
- 238000002360 preparation method Methods 0.000 claims description 28
- 241001092040 Crataegus Species 0.000 claims description 25
- 241001083492 Trapa Species 0.000 claims description 22
- 238000007654 immersion Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 5
- 229920002261 Corn starch Polymers 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 239000008120 corn starch Substances 0.000 claims description 4
- 229940099112 cornstarch Drugs 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- 238000002386 leaching Methods 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000029078 coronary artery disease Diseases 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 230000002792 vascular Effects 0.000 abstract description 4
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 3
- 238000009472 formulation Methods 0.000 abstract description 3
- 235000008935 nutritious Nutrition 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 240000001085 Trapa natans Species 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 206010020772 Hypertension Diseases 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000006837 decompression Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 241000256844 Apis mellifera Species 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000035487 diastolic blood pressure Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 235000011305 Capsella bursa pastoris Nutrition 0.000 description 2
- 240000008867 Capsella bursa-pastoris Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- QHBZHVUGQROELI-SOFGYWHQSA-N (E)-10-hydroxydec-2-enoic acid Chemical compound OCCCCCCC\C=C\C(O)=O QHBZHVUGQROELI-SOFGYWHQSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- QHBZHVUGQROELI-UHFFFAOYSA-N Royal Jelly acid Natural products OCCCCCCCC=CC(O)=O QHBZHVUGQROELI-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Jellies, Jams, And Syrups (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
一种降血压的固体饮料，其是由以下重量份的原料制备而成：蜂王浆30‑40份、蜂蜜27‑33份、蜂胶7‑13份、菊花40‑50份、山楂11‑17份、荸荠10‑16份、胡萝卜12‑18份。采用本发明配方制备出的降血压固体饮料，口感好，携带方便，速溶快，营养丰富，长期饮用，不仅能够降血压，同时还能防治血管硬化、心绞痛和冠心病等病的发生。
Description
技术领域
本发明属于食品加工技术领域，具体涉及一种降血压的固体饮料。
技术背景
高血压病系一种常见的疑难病症，它以动脉升高为主要特征，可并发心、脑、肾、视网膜等疾症，引起头晕、头痛、烦躁、肢体麻木、眼睛肿胀等，威胁着人类的身体健康。高血压的发生主要是因为人们在平时摄入了过多的脂肪，血液中胆固醇、甘油三脂过高所致，同时，血管也像肌肉及其它组织器官一样，随着年龄增加，逐步出现老化、硬化。这时就需要较高一些的血压来促进血液循环。但是，如果血压过高，而且长期居高不下，会进一步加快血管硬化，导致血栓形成、脑动脉血管破裂等危险性疾病。目前，国内外对高血压的治疗主要是通过药物降压，但是只能控制血压，不能根治，存在长期服用和副作用大等缺点。长期服用即“一次得病，终身服药”，副作用大即长期服用降压药会引起肝功能受损、肾功能异常、心律失常、心肌收缩力下降等症状。
发明内容
本发明的目的就在于为解决现有技术的不足而提供一种口感好，携带方便，速溶快，营养全面丰富，能够降血压，且长期饮用对人体无任何副作用的降血压固体饮料。
本发明的目的是以下述技术方案实现的：
一种降血压的固体饮料，其是由以下重量份的原料制备而成：蜂王浆30-40份、蜂蜜27-33份、蜂胶7-13份、菊花40-50份、山楂11-17份、荸荠10-16份、胡萝卜12-18份。
上述的一种降血压的固体饮料，其中，是由以下重量份的原料制备而成：蜂王浆35份、蜂蜜30份、蜂胶10份、菊花45份、山楂14份、荸荠13份、胡萝卜15份。
上述降血压固体饮料的制备方法，包括以下步骤：
（1）称取上述重量份的胡萝卜、山楂、荸荠，并洗净，将胡萝卜切成段，山楂去籽，荸荠去皮；然后将胡萝卜、山楂、荸荠和适量的水一起放入搅拌机中打浆，过滤，取滤液待用；
（2）蜂胶液的制备；
（3）菊花浸液的制备；
（4）将蜂蜜、蜂王浆、步骤（2）中制备的蜂胶液及步骤（3）中制备的菊花浸液加入步骤（1）中获得的滤液中，混合均匀，浓缩至相对密度为1.15-1.25；
（5）加入麦芽糊精和玉米淀粉，喷雾干燥，制得。
上述的降血压固体饮料的制备方法，其中，步骤（2）制备蜂胶液具体包括如下步骤：称取上述重量份的蜂胶，加入20-25倍原料重量的乙醇水溶液，浸泡10-12h后过滤，加热滤液去除乙醇和水，即得蜂胶液。
上述的降血压固体饮料的制备方法，其中，步骤（3）制备菊花浸液具体包括如下步骤：称取上述重量份的菊花，加入10-15倍原料重量的水浸泡20-30min后，大火煎煮，水沸10-20min后，文火煮20-30min，滤出药液，即得菊花浸液。
上述的降血压固体饮料的制备方法，其中，所述乙醇水溶液的质量分数为70-90%。
本发明配方中，蜂王浆是一种高活性成分的超级营养品，其营养成分易于吸收，蜂王浆中含有的王浆酸（10-羟基-葵烯酸）可以降低血压和软化血管，此外，蜂王浆中含有人体必需的十余种维生素，能平衡脂肪代谢和糖代谢，可有效降低肥胖者的高血脂和高血糖；蜂蜜其性平，味苦、辛、微甘，具有双向调节血压的作用，当血压较高时，蜂蜜可促使冠状血管扩张，使血压下降，当血压下降到一定程度时，蜂蜜中的乙酰胆碱，能帮助患者体内胆固醇的运输和利用，进而又能使血压升高，除此之外，蜂蜜对脑功能有促进效果，产生使血压维持正常的自律调整作用, 因此蜂蜜可用于防治动脉硬化和冠心病；蜂胶中含有的黄酮类化合物槲皮素可以减少过氧化脂质对血管的危害，阻止血管硬化，而且还能有效地降低甘油三酯含量，减少血小板聚集，改善微循环，缓解过高的血压；菊花具有降血压、消除癌细胞、扩张冠状动脉和抑菌的作用，长期饮用能增加人体钙质、调节心肌功能、降低胆固醇，适合中老年人和预防流行性结膜炎时饮用。对肝火旺、用眼过度导致的双眼干涩也有较好的疗效；山楂中的总黄酮有扩张血管和持久降压的作用，此外，山楂还能显著降低血清胆固醇及甘油三酯，有效防治动脉粥样硬化，山楂还能通过增强心肌收缩力、增加心输出量、扩张冠状动脉血管、增加冠脉血流量、降低心肌耗氧量等起到强心和预防心绞痛的作用；荸荠中含有一种不耐热的抗病成分荸荠英，具有降压、抗癌的作用；胡萝卜中含有丰富的胡萝卜素，能够增加冠状动脉中血液的流量，清除血管中的血脂，防治血管的硬化，降低人体中的胆固醇和血压。
上述原料中，菊花、山楂、胡萝卜、荸荠均为凉性，长期饮用，对高血压患者的脾胃不好，加入蜂蜜、蜂王浆、蜂胶中和了上述原料的凉性，对于高血压患者来说可以长期饮用，对人体无副作用，蜂蜜、山楂、胡萝卜能够调和固体饮料的口感，使固体饮料的口感好，且携带方便，速溶快，营养丰富；除此之外，上述原料配伍，长期饮用不仅能够降血压，使血压维持在正常值内，同时还能防治血管硬化、心绞痛和冠心病等病症的发生。
具体实施方式
实施例1
一种降血压的固体饮料，其由以下重量份的原料制备而成：蜂王浆30-40份、蜂蜜27-33份、蜂胶7-13份、菊花40-50份、山楂11-17份、荸荠10-16份、胡萝卜12-18份。
上述降血压的固体饮料的制备方法，包括以下步骤：
（1）称取上述重量份的胡萝卜、山楂、荸荠，并洗净，将胡萝卜切成4-5cm段，山楂去籽，荸荠去皮；然后将胡萝卜、山楂、荸荠和适量的水一起放入搅拌机中打浆，过滤，取滤液待用；
（2）蜂胶液的制备；称取上述重量份的蜂胶，加入20-25倍原料重量的质量分数为70-90%乙醇水溶液，浸泡10-12h后过滤，加热滤液去除乙醇和水，即得蜂胶液；
（3）菊花浸液的制备；称取上述重量份的菊花，加入10-15倍原料重量的水浸泡20-30min后，大火煎煮，水沸10-20min后，文火煮20-30min，滤出药液，即得菊花浸液；
（4）将蜂蜜、蜂王浆、步骤（2）中制备的蜂胶液及步骤（3）中制备的菊花浸液加入步骤（1）中获得的滤液中，混合均匀，浓缩至相对密度为1.15-1.25；
（5）加入麦芽糊精和玉米淀粉，喷雾干燥，制得。
实施例2
一种降血压的固体饮料，其由以下重量份的原料制备而成：蜂王浆35份、蜂蜜30份、蜂胶10份、菊花45份、山楂14份、荸荠13份、胡萝卜15份。
上述降血压的固体饮料的制备方法，包括以下步骤：
（1）称取上述重量份的胡萝卜、山楂、荸荠，并洗净，将胡萝卜切成4-5cm段，山楂去籽，荸荠去皮；然后将胡萝卜、山楂、荸荠和适量的水一起放入搅拌机中打浆，过滤，取滤液待用；
（2）蜂胶液的制备；称取上述重量份的蜂胶，加入22倍原料重量的质量分数为80%乙醇水溶液，浸泡11h后过滤，加热滤液去除乙醇和水，即得蜂胶液；
（3）菊花浸液的制备；称取上述重量份的菊花，加入12倍原料重量的水浸泡25min后，大火煎煮，水沸15min后，文火煮25min，滤出药液，即得菊花浸液；
（4）将蜂蜜、蜂王浆、步骤（2）中制备的蜂胶液及步骤（3）中制备的菊花浸液加入步骤（1）中获得的滤液中，混合均匀，浓缩至相对密度为1.20；
（5）加入麦芽糊精和玉米淀粉，喷雾干燥，制得。
采用上述配比和方法制备出的降血压固体饮料，口感好，携带方便，速溶快，营养丰富，长期饮用，不仅能够降血压，同时还能防治血管硬化、心绞痛和冠心病等病的发生。
对比例1
一种降血压的固体饮料，其由以下重量份的原料制备而成：蜂王浆35份、蜂胶10份、菊花45份、山楂14份、荸荠13份、胡萝卜15份。具体制备方法同实施例2。与实施例2相比，未添加蜂蜜，采用上述配比和方法制备出的降血压固体饮料，口感欠佳，长期饮用能够降血压，但是不能将血压维持在正常值内，容易造成血压较大的浮动。
对比例2
一种降血压的固体饮料，其由以下重量份的原料制备而成：蜂蜜30份、菊花45份、山楂14份、荸荠13份、胡萝卜15份。具体制备方法同实施例2。与实施例2相比，未添加蜂王浆、蜂胶，采用上述配比和方法制备出的降血压固体饮料，口感欠佳，且所制得的固体饮料偏寒性，不适宜长期饮用，降血压效果也不近理想。。
本发明实施例3-18提供的治疗口腔溃疡的中药的配方见表1-2。
表1
表2
功效实验
高血压患者150例，其中男100例，女50例，年龄40-75岁，随机分为三组，分别为实施例2组（饮用实施例2制备出的降血压固体饮料）、对比例1组（饮用对比例1制备出的降血压固体饮料）、对比例2组（饮用对比例2制备出的降血压固体饮料），每人每日在早餐时饮用一次，每次一块固体饮料，用150mL溶解，连续饮用3个月。
中医症候诊断标准参照卫生部《中药新药治疗高血压病临床研究指导原则》，高血压诊断标准参照世界卫生组织和中国高血压联盟制定的《高血压防治指南》。
疗效标准：参照卫生部《中药新药治疗高血压病临床研究指导原则》中制定的降压疗效标准。显效：（1）舒张压降低≥1.3KPa，并达到正常范围；（2）舒张压虽未下降至正常，但已下降≥2.7KPa，须具备其中1项。有效：（1）舒张压下降＜1.3KPa，但已达到正常范围；（2）舒张压较饮用降压固体饮料前下降1.3-2.5KPa，但未达到正常范围；（3）收缩压较饮用降压固体饮料前下降≥4.0KPa，须具备其中1项。无效：未达到上述标准。
连续饮用降血压固体饮料3个月后疗效评价如表3：
表3
从表3中可以看出，虽然实施例1组、对比例1组和对比例2组制备出的降血压固体饮料对降血压均有一定的疗效，但是实施例1组对于降血压疗效最好，明显优于对比例1组和对比例2组。
Claims (6)
1.一种降血压的固体饮料，其特征在于，由以下重量份的原料制备而成：蜂王浆30-40份、蜂蜜27-33份、蜂胶7-13份、菊花40-50份、山楂11-17份、荸荠10-16份、胡萝卜12-18份。
2.如权利要求1所述的一种降血压的固体饮料，其特征在于，由以下重量份的原料制备而成：蜂王浆35份、蜂蜜30份、蜂胶10份、菊花45份、山楂14份、荸荠13份、胡萝卜15份。
3.如权利要求1-2任一项所述降血压固体饮料的制备方法，其特征在于包括以下步骤：
（1）称取上述重量份的胡萝卜、山楂、荸荠，并洗净，将胡萝卜切成段，山楂去籽，荸荠去皮；然后将胡萝卜、山楂、荸荠和适量的水一起放入搅拌机中打浆，过滤，取滤液待用；
（2）蜂胶液的制备；
（3）菊花浸液的制备；
（4）将蜂蜜、蜂王浆、步骤（2）中制备的蜂胶液及步骤（3）中制备的菊花浸液加入步骤（1）中获得的滤液中，混合均匀，浓缩至相对密度为1.15-1.25；
（5）加入麦芽糊精和玉米淀粉，喷雾干燥，制得。
4.如权利要求3所述的降血压固体饮料的制备方法，其特征在于，步骤（2）制备蜂胶液具体包括如下步骤：称取上述重量份的蜂胶，加入20-25倍原料重量的乙醇水溶液，浸泡10-12h后过滤，加热滤液去除乙醇和水，即得蜂胶液。
5.如权利要求3所述的降血压固体饮料的制备方法，其特征在于，步骤（3）制备菊花浸液具体包括如下步骤：称取上述重量份的菊花，加入10-15倍原料重量的水浸泡20-30min后，大火煎煮，水沸10-20min后，文火煮20-30min，滤出药液，即得菊花浸液。
6.如权利要求4所述的降血压固体饮料的制备方法，其特征在于，所述乙醇水溶液的质量分数为70-90%。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710494683.4A CN107259283A (zh) | 2017-06-26 | 2017-06-26 | 一种降血压的固体饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710494683.4A CN107259283A (zh) | 2017-06-26 | 2017-06-26 | 一种降血压的固体饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107259283A true CN107259283A (zh) | 2017-10-20 |
Family
ID=60068781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710494683.4A Pending CN107259283A (zh) | 2017-06-26 | 2017-06-26 | 一种降血压的固体饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107259283A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107897824A (zh) * | 2017-11-23 | 2018-04-13 | 刘春明 | 一种降血压血脂的食品及制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101223988A (zh) * | 2008-02-03 | 2008-07-23 | 王东桥 | 解酒护肝、健脾养胃的保健饮料及其制备方法 |
-
2017
- 2017-06-26 CN CN201710494683.4A patent/CN107259283A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101223988A (zh) * | 2008-02-03 | 2008-07-23 | 王东桥 | 解酒护肝、健脾养胃的保健饮料及其制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107897824A (zh) * | 2017-11-23 | 2018-04-13 | 刘春明 | 一种降血压血脂的食品及制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103960729B (zh) | 低糖黑蒜花卉饮料及制备方法 | |
| CN106266700A (zh) | 一种沙棘组方袋泡型茶剂调配及制作方法 | |
| CN104366178A (zh) | 一种蜂王浆蜜及其制备方法 | |
| CN104739925A (zh) | 一种治疗痤疮的组合物及其制备方法 | |
| CN104186750A (zh) | 杜仲花草养生茶 | |
| CN101828715B (zh) | 一种用于高血脂、高血压、高胆固醇病人的保健食品 | |
| CN103519267A (zh) | 一种蜂蜜醋保健饮料及其制作方法 | |
| CN103609938A (zh) | 一种花羹及其制备方法 | |
| KR20140137155A (ko) | 원적외선수가 포함되는 발효 흑한방약재 제조방법 | |
| CN107259283A (zh) | 一种降血压的固体饮料 | |
| CN105341574A (zh) | 一种牛蒡饮料的配方及生产工艺 | |
| CN105981853A (zh) | 一种营养功能丰富的温和的暖茶饮料配方 | |
| CN106260348A (zh) | 一种三叶降压袋泡茶及其制备方法 | |
| CN105687049A (zh) | 可有效去除面部暗疮的洗浴盐及制备方法 | |
| KR20180121435A (ko) | 원적외선 증류수가 포함되는 발효 흑한방약재 제조방법 | |
| CN109289017A (zh) | 用于清理血管和血液的组合物及制备方法 | |
| CN107647041A (zh) | 一种降三高的保健茶及其制备方法 | |
| CN104642845A (zh) | 一种柑橘龙眼蜂蜜 | |
| KR20120093127A (ko) | 발효 흑한방약재 제조방법 | |
| CN102755444A (zh) | 一种用于治疗高血脂症的中药组合物及其制备方法 | |
| Róbertsdóttir | Icelandic herbs and their medicinal uses | |
| CN106070912A (zh) | 一种三叶降压茶凉茶饮料及其制备方法 | |
| CN107028173A (zh) | 一种百草青液保健品及其制备方法 | |
| CN104642848A (zh) | 一种葵花杜鹃养颜蜂蜜 | |
| CN106138444A (zh) | 一种治疗烫伤的药膏及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171020 |